Study breathing treatment and early immunity in newborns after COVID
Part of Mental health clinical trials.
This study looks at how newborns’ bodies are affected by COVID-19 around birth and whether a breathing support treatment (inhaled nitric oxide) changes outcomes. It also compares COVID-exposed babies and a similar group of babies without COVID who are not receiving the breathing treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 24 and 41 weeks of pregnancy (not earlier than 24 weeks).
- Your baby is currently within the first 3 months of life and is cared for at the hospital’s maternity or newborn unit.
- Your baby must be in one of these groups: COVID around birth (antenatal positive test in pregnancy or baby positive throat/stool PCR) OR needs inhaled nitric oxide for severe breathing/heart-lung problems OR is a matched control without COVID and without inhaled nitric oxide.
- Both parents can provide written consent for the study.
- Both parents are able to read and understand French (the study cannot be joined if they cannot).
- Your baby does not have certain severe brain injuries (specific serious brain ultrasound/MRI findings).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This trial tests a portable device that delivers nitric oxide gas to help newborns with severe breathing problems and high blood pressure in the lungs. It aims to see if this treatment improves oxygen levels and supports recovery.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This study looks at whether an inhaled nitric oxide generator and delivery system can help newborns with high lung blood pressure (pulmonary hypertension). It may help improve oxygen levels during breathing support, but it requires specific medical eligibility and informed consent.
This study looks at how different pregnancy and birth factors may contribute to airway inflammation in infants who wheeze or have lung conditions. It may help researchers understand why some babies get ongoing breathing problems and how early influences could be linked.
This study checks how a type of breathing machine support affects brain health in very premature infants. It may help doctors choose safer breathing support strategies to protect the brain.
Hear when a new Neurodevelopmental Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.